Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of Glofitamab in combination with Rituximab-CHOP in untreated diffuse large B-cell lymphoma patients at high ci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Glofitamab (glofitamab)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING